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was	 still	 present	 in	 the	 apical	 compartment	 as	 the	 esterified	 form.	 Structure-activity	 relationships	 are	 further	
discussed.	Animal	 experiments	usingyeast	 and	algae	 sources	 in	different	 types	of	matrices	 confirm	 the	 role	of	
source	and	formulation	in	the	bioavailability	potential	of	astaxanthin.
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 INTRODUCTION
Astaxanthin	 belongs	 to	 the	 family	 of	 carot-











ers	 working	 on	 in	 vitro	 system	 of	 human	 blood	
cells	 treated	 with	 various	 carotenoids	 and	 then	




that	 it	 is	 50	 times	 more	 effective	 in	 preventing	






immune	 response	 modulation,	 pigmentation,	
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mammals	and	most	fish	are	unable	to	convert	other	
dietary	 carotenoids	 to	 astaxanthin,	 crustaceans	
(such	as	shrimp)	and	some	fish	species	(koi)	have	








mackerel,	 salmon	or	 other	 coloured	 fish.	 In	wild	













ly	 used	 in	 animal	 feed,	 while	 production	 by	 the	







The	 various	 stages	 of	 transportation,	 diges-
tion,	 absorption	 and	 transport	 in	 the	 plasma	 of	
dietary	 carotenoids	were	 examined	 in	mammals	
(Furr&	 Clark,	 1997)but	 also	 because	 these	 com-
pounds	have	been	associated	with	reducing	risks	
of	 certain	 cancers	 and	 chronic	 diseases.	 Full	 un-
derstanding	of	 carotenoid	metabolism	 is	 compli-
cated	by	a	number	of	 factors:	variations	 in	phys-
iochemical	properties	among	carotenoids;	altered	
carotenoid	 utilization	 as	 a	 result	 of	 the	 normal	
vicissitudes	of	lipid	absorption	and	transport;	di-




usually	 transported	by	very	 low	density	 lipopro-
teins	 (VLDL)	and	 low	density	 lipoproteins	 (LDL)	




investigated	 the	 bioavailability	 of	 astaxanthin	




anthin	E/Z	 and	R/S	 isomers	 in	plasma	and	 lipo-
protein	 fractions	were	 studied	 in	 3	middle-aged	
male	volunteers	(37-43	years		but	none	so	far	on	
fermentative	sources	such	as	yeast	or	bacteria.	
To	 our	 knowledge,	 no	 report	 comparing	 the	
different	 sources	 of	 astaxanthin	 has	 been	 pub-
lished.	 This	 study	 therefore	 aims	 to	 compare	 on	a cellular epithelial transport model four sources 
of	astaxanthin	used	in	animal	feed,	some	of	which	are used or intended for human consumption.
MATERIALS AND METHODS 
All	 reagents	were	purchased	 from	Sigma	Al-
drich	 (France),	 except	 for	 the	 different	 astaxan-




tocol	 (Mimoun-Benarroch	 et al.,	 2011)	 to	mimic	
the	 intestinal	 absorption	 of	 lipophilic	 molecules	
solubilized	 in	 the	 form	of	 bile	 salt	micelles.	 This	
formulation,	 based	 on	 the	 composition	 of	 post-
prandial	 duodenal	 contents	 in	 humans	 (Armand	
et al.,	 1996),	 appears	 to	 be	 the	 closest	 to	 physi-
ological	conditions.	In	brief,	cholesterol	(0.1	mM),	
phosphatidyl	choline	(0.5	mM),	lyso-phosphatidyl	
choline	 (1.5	mM),	monoolein	 (0.03	mM),	 sodium	
oleate	 (0.5	 mM)	 and	 astaxanthin	 (5	 µM)	 were	
mixed	 in	 a	 methanol:chloroform	 solution	 (2/1;	
v/v)	and	evaporated	under	a	stream	of	nitrogen.	
Sodium	taurocholate	(5	mM)	was	then	diluted	in	
half	 a	 volume	 of	 culture	medium	 (DMEM)	with-
out	 serum	and	without	phenol	 red	and	added	 to	
the	 dried	 lipid	 residue	 and	 vigorously	mixed	 by	
sonication	at	25	W	for	3	min.	When	the	medium	
is	 translucent,	 the	 second	volume	of	 culture	me-
dium	is	added	and	the	solution	stirred	overnight	
to	allow	 the	micelles	 to	 stabilize.	The	 solution	 is	
filtered	 (0.2	µm)	before	 treatment	 to	 retain	only	
the	uniform	size	of	micelles.
Media	 and	 cell	 culture	 solutions	 were	 pur-
chased	 from	 Life	 Technologies	 (France).	 Caco2/
TC7	 cellswere	 a	 generous	 gift	 from	 Dr	 Monique	
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Rousset	 (Université	 Pierre	 et	 Marie	 Curie-Paris	
6,	 UMR	 S872,	 Les	 Cordeliers,	 Paris).	 They	 were	
cultured	 in	 DMEM	 Glutamax	 medium,	 4.5	 g/L	
glucose,	1	%	antibiotics,	1	%	nonessential	amino	
acids,	 20	 %	 inactivated	 foetal	 calf	 serum,	 in	 an	
incubator	 at	 37	 °C	 and	 10	%	 CO
2
.	 To	mimic	 the	
enterocyte	 transport,	 the	 cells	 were	 seeded	 at	 a	
density	of	0.25	×	106	cells	in	inserts	containing	a	
semi	permeable	PET	membrane	 (23.1	mm	 in	di-
ameter;	 1	 µm	 porosity)	 placed	 in	 6-well	 plates	
(Becton	Dickinson).	The	use	of	inserts	allows	dif-
ferential	 access	 to	 the	 two	 poles	 of	 the	 cell,	 the	
apical	 compartment	 representing	 the	 intestinal	
lumen	 and	 basolateral	 compartment	 represent-
ing	the	internal	circulation.	In	brief,	cells	were	cul-
tured	with	complete	medium	(20%	serum)	for	7	















incubation	 by	 collection	 of	 the	 different	 media	
(apical,	basolateral).	Finally	the	cellular	layer	was	
washed	with	PBS	before	being	 scraped	 from	 the	
insert	and	collected	in	500	µl	PBS.	Samples	were	
kept	frozen	(-80	°C)	until	analysis.
The	 extraction	 protocol	 is	 adapted	 from	
Mercke-Odeberg	et al(2003).	Briefly,	6	volumes	of	
hexane	and	6	volumes	of	acetone	were	added,	the	
sample	 vortexed	 for	 1	min	 before	 centrifugation	
for	 5	 min	 at	 2500	 rpm,	 room	 temperature.	 The	
organic	phase	was	transferred	to	a	new	tube	and	
evaporated	 under	 nitrogen	 flux.	 The	 astaxanthin	
pellet	was	recovered	in	200	μL	acetone	for	HPLC	
analysis.	 In	 the	 case	of	 tests	 on	 the	 algae	 source	










stream.	 The	 pellet	 was	 recovered	 in	 1.5	 mL	 of	
acetone,	 dissolved	 by	 ultrasound	 for	 30	 sec	 and	
filtered	(0.45	µm)	prior	to	HPLC	analysis.The	HPLC	






Optical isomers (%) Geometrical isomers (%) Derivation (%)
3R,3’R 3R,3’S 3S,3’S All-trans Cis Free
Mono-
ester Diester
farmed salmon 2.5-8 25 50 25
wild salmon 5-30 12-17 2-6 78-85




98 - 2 70-90 10-30 100 - -




4 8 88 70 30 5 85 15
Synthetic 100000 25 50 25 65-75 25-35 100 - -
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isocratic	 condition	 using	 4%	 solvent	 A	 (ddH
2
O),	
15%	 of	 solvent	 B	 (MTBE)	 and	 81%	 solvent	 C	
(Methanol),	carotenoids	were	eluted	over	50	min	
with	a	 linear	gradient	of	15	to	90%	of	solvent	B,	
solvent	 A	 remaining	 constant	 throughout	 the	
elution	time.	The	column	was	re-equilibrated	 for	
5	min	between	each	analysis.	Quantification	was	
performed	 using	 a	 standard	 curve	 of	 all-trans	




independent	 experiments.	 Statistical	 tests	 were	
performed	 using	 SPSS	 v17.0	 for	Windows	 (SPSS	









The	 absorption	 of	 astaxanthin	 present	 in	
the	 four	sources	was	time-dependent	with	a	me-
dian	value	 for	 the	unabsorbed	 fraction	of	41.2%,	
53.8%,	48.5%,	35.6%	after	3	hours	of	 treatment	
and	 15.6%,	 44.2%,	 2.6%,	 6.7%	 after	 6	 hours	 of	
treatmentfor	the	yeast,	algae,	bacterium	and	syn-
thetic	 sources,	 respectively	 (Fig.	 1).	 Although	 a	
lower	rate	of	absorption	is	observed	at	3	hours	be-
tween	the	esterified	and	free	forms,	the	difference	










yeast	 (p<0.01)	 and	 algae	 (p<0.001)	 astaxanthin	
but	 not	 the	 two	 other	 sources.Therefore	 even	 if	




free)	 and	 the	 apical,	 basal	 (DMED	 10%	 serum)	
and	cell	fractions	were	collected	after	3	or	6	hours.	
Carotenoids	 were	 quantified	 and	 expressed	 as	
percentage	 of	 unabsorbed	 molecule	 (apical).	 All	datapoints are presented on the scatterplot for 
yeast,	 algae,	 bacterium	 and	 synthetic	 sources,	
in	 order.	 Dunn’s	 pair-to-pair	 comparisons	 were	
performed	for	statistical	significance.	*	p<0.05;	***	
p<0.0005
Over	 a	 third	 of	 astaxanthin	 remained	 unab-
sorbed	 (44.2%)	 after	 6	 hours	 for	 the	 algae	
source	(Fig.	1).	As	 the	percentage	of	unabsorbed	
astaxanthin	 is	 not	 greatly	 improved	 between	 3	
and	 6	 hours	 of	 treatment	 (non-significant),	 the	
chromatograms	 confirm	 that	 only	 esterified	
astaxanthin	 remains	 in	 the	 apical	medium	while	
3H
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only	 free	 form	 is	 present	 in	 the	 cells	 (data	 not	
shown).	 This	 suggests	 a	 role	 for	 hydrolysis	 of	
astaxanthin	esters	 leading	 to	delayed	absorption	of the molecule. 
Transfer	to	the	basolateral	side	was	very	poor	
for	 astaxanthin	 (up	 to	2%,	whatever	 the	 source)	
while	 it	was	 fast	 and	complete	 for	beta-carotene	
(Tab.2).	 This	 difference	 is	 highly	 significant	
(p<0.001)	 against	 all	 sources	 of	 astaxanthin	 at	
both	3	and	6	hours	of	treatment.	From	the	different	
sources	 of	 astaxanthin,	 there	 is	 no	 molecule	
detected	 in	 the	 basolateral	 compartment	 with	
algae	 and	 the	 transfer	 through	 the	 basolateral	
membrane	seems	to	be	time-dependent	for	yeast	
and	synthetic	astaxanthin,	although	very	slow,	but	
not	 for	 the	 bacterial	 astaxanthin.	 The	 question	
remains	 as	 to	 why	 the	 astaxanthin	 accumulates	








than	 a	 couple	 of	 decades	 old.	 As	 a	 consequence,	
studies	 of	 this	 carotenoid	 are	 relatively	 sparse.	
In	 addition,	 investigations	 on	 the	 bioavailability	
represent	 only	 a	 very	 small	 part	 of	 the	 available	
publications,	 which	 are	 mostly	 on	 physiological	
benefits.	 It	 may	 be	 as	 well	 due	 to	 the	 highly	
competitive	market	leading	to	preclinical	research	
remaining	 confidential.	 However	 it	 is	 possible	
to	 compare	 our	 results	with	 those	 published	 on	other carotenoids. 
O’Sullivan	et al.	(2004)	showed	that	astaxan-
thin	was	better	accumulated	into	Caco-2	cells	over	
a	 24-hours	 period	 compared	 to	 beta-carotene,	









on	 a	 transwell	 culture	 set-up	 when	 comparing	
astaxanthin	 to	 beta-carotene	 presented	 on	 the	
apical	 side	 in	 Tween40	with	 chylomicron-stimu-
lating	molecules	for	16	hours	(O’Sullivan,	Ryan	&	
O’Brien,	 2007).	 Sy	 et al.	 (2012)	 did	 not	 find	 any	
carotenoid	 into	 the	basolateral	medium	after	a	3	





















%	Absorbed	(BL+C) of	which	in	BL %	Absorbed	(BL+C) of	which	in	BL
P.rho 59.22	(6.75) b 1.01	(0.50) b 87.83	(7.54) b 2.20	(1.69) b
P.car 51.94	(13.83) ab 1.19	(2.08) b 94.08	(6.58) c 0.75	(1.58) a
H.plu 45.26	(5.29) a 0.00	(0.00) a 60.20	(9.50) a 0.00	(0.00) a
Synth 64.38	(7.78) b 1.00	(0.95) b 90.78	(4.70) bc 2.54	(1.70) b
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is	 a	 common	 feature	 of	 lipid-soluble	 molecules.	
Carboxyl	 ester	 lipase,	 also	 known	 as	 cholesterol	esterase is produced in the pancreatic juice for an 
activity	at	the	brush	border	(Ikeda	et al.,	2003)	and	
is	the	main	actor	of	hydrolysis	of	carotenoid	esters	
in	 the	 intestinal	 lumen	 before	 absorption	 of	 the	
free	form	by	the	enterocytes.	However,	in	a	similar	
experimental	 setup,	 fucoxanthin	 was	 hydrolysed	
when	exposed	 to	Caco-2	cells	producing	 the	 free	





border	 is	consistent	with	previous	reports	 (Ann-aert et al.,	1997;	Spalingeret al.,	1998)”container-
title”:”Biochimica	Et	Biophysica	Acta”,”page”:”119-
127”,”volume”:”1393”,”issue”:”1”,”source”:”Pub
Med”,”abstract”:”Dietary	 triglycerides,	 the	 major	
precursors	of	long	chain	fatty	acids	(FA.	Similarly,	
absorption	of	 zeaxanthin,	 another	 xanthophyll	 is	
facilitated	 by	 prior	 hydrolysis	 of	 its	 esters	 (Chit-




activity	 of	 the	 cells.	 Further	 investigations	 need	
to	be	performed	as	well	to	assess	the	esterase	ac-
tivity	 in	 cells	 exposed	 to	 free	 and	 ester	 forms	of	
astaxanthin.	 In	 addition,	 it	may	be	 interesting	 to	
do	a	pre-digestion	with	pancreatic	 juice.	The	up-
take	and	role	of	esterified	astaxanthin	on	mucosal	
absorption	 patterns	 remain	 unclear	 at	 this	 time.	










Animal	 studies	 (data	 not	 shown)	 have	 been	
performed	 in	 order	 to	 better	 understand	 the	impact of the source and the food matrix in 
absorption	 parameters.	 A	 study	 on	 hamsters	
showed	 that	 powder	matrix	 greatly	 reduced	 the	
plasma	 recovery	 of	 astaxanthin	 from	 the	 yeast	
Phaffia rhodozyma	and	delays	the	peak	of	plasma	
concentration	by	up	to	4	hours.	This	is	in	agreement	
with	 the	 clinical	 study	 from	 Mercke-Odeberg	 et 
al	 (2003)	 showing	 an	 increased	 bioavailability	
of	 astaxanthin	 from	 the	 algae	 Haematococcus 
pluvialis	 in	 lipid	 compared	 to	 powder	 matrix.	
Another	 study	 in	 rats	 compared	 the	 two	 main	
sources	 (algae	 and	 yeast)	 prepared	 in	 the	 same	
lipid	 carrier	 (safflower	 oil).	 Data	 showed	 that	
this	 specific	 carrier	 was	 not	 suitable	 to	 dissolve	
the	 free	 form	 (yeast)	 into	 a	 solution	 but	 rather	
into	 a	 fine	 suspension	 of	 astaxanthin	 crystals.	
Hence,	the	bioavailability	was	much	lower	for	the	
yeast	compared	to	algae	due	to	the	exchange	area	
that	 was	much	 lower	 (Ajinomoto	 Foods	 Europe,	
personal	data).
These	 studies	 were	 thus	 contradictory	 with	the in vitro	data	regarding	the	rate	of	absorption	










The	 expression	 of	 several	 lipid	 carriers	
was	 measured	 by	 RT-qPCR	 after	 3	 and	 6	 hours	
of	 treatment	 (data	 not	 shown).	 The	 maximum	
expression	 was	 observed	 at	 6	 hours,	 when	 the	
absorption	 was	 mostly	 complete.	 The	 activation	
therefore	 is	not	necessarily	directly	related	to	an	
active	transport	of	the	molecules.	Incubation	with	
carotenoid-free	 micelles,	 a	 wide	 range	 of	 genes	
were	modulated,	indicating	that	most	carriers	were	
modulated	 primarily	 by	 bile	 acids,	 in	 agreement	
with	the	physiological	mechanisms	of	absorption	
of	 dietary	 lipids.	 When	 comparing	 astaxanthin	
treatments	against	micelles,	very	few	modulations	
were	 significant.	 Astaxanthin	 from	 the	 yeast	
Phaffia rhodozyma stimulated the expression 
of	 a	 range	 of	 genes	 at	 6	 hours,	 including	 Fabp2	
(p<0.05),	 Scarb1	 (p<0.05)	 and	 Scp2	 (p<0.01).	
Astaxanthin	 from	 algae	 Haematococcus pluvialis 
stimulated	expression	of	Scarb1	(p<0.05)	and	Scp2	
(p<0.05)	at	6	hours.	Synthetic	astaxanthin,	finally,	
stimulated	 the	 expression	 of	 Scp2	 (p<0.05)	 at	 6	
hours,	 while	 bacterial	 astaxanthin	 did	 not	 seem	
to	significantly	affect	any	gene	expression.	All	this	
may	 suggest	 a	 structure-dependent	 activation	
MIMOUN-BENARROCH	et al.
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of	 the	 lipid	 carriers	 involved	 in	 the	 uptake	 or	
at	 least	 stimulated	 by	 astaxanthin	 isomers.	 In	
the	case	of	Scp2,	a	possibility	may	be	 the	role	of	
the	 geometrical	 isomer	 cis-astaxanthin	 which	 is	
virtually	 absent	 from	 the	 bacterial	 extracts	 and	
present	in	up	to	30%	in	the	other	forms	(Tab.	1).






or	 lutein.	 An	 inhibitor	 of	 the	 SR-B1	 transporter	
also	 had	 a	 partial	 effect	 on	 carotenoids	 uptake,	
suggesting	 a	 role	 in	 active	 transport	 of	 beta-car-
otene.	The	results	of	Reboul	et al.(2005),	suggest-
ing	 that	 lutein	 is	 at	 least	 partially	 carried	 by	 an	
active	 mechanism	 involving	 the	 SR-B1	 receptor.	
Further	work	reviewed	in	2013	point	to	the	role	of	
SR-B1	carrier	protein	for	a	range	of	carotenes	and	
xanthophylls(Reboul,	 2013).	 The	 corresponding	
gene,	 Scarb1	 was	 modulated	 by	 both	 beta-caro-
tene	and	some	sources	of	astaxanthin	in	our	study.
The	inhibition	of	the	expression	of	AbcA1	is	how-
ever	inconsistent	with	the	putative	role	of	the	car-rier protein in the excretion of carotenoids on the 
basolateral	membrane	of	the	enterocyte	(Reboul,	



















be	 involved	 in	 facilitated	 uptake	 of	 other	 lipids	
rather	 than	astaxanthin	 itself.	With	 this	 in	mind,	
most	 forms	 of	 astaxanthin	 seem	 to	 particularly	
target	the	intestinal	sterol	carrier	protein	(SCP2)	
and	modulate	 bile	 acid	 excretion	 into	 the	 lumen	
and formation of lipid carriers such as micelles for 








We	have	 observed	 through	 this	 series	 of	 ex-
periments	variation	in	the	bioavailability	and	gene	

















Our	 second	 conclusion	 is	 based	 on	 the	 ex-






suggests	 possible	 physiological	 consequences	 of	
modulating	these	carriers.	
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